Which patients should be screened for colorectal cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colorectal Cancer Screening: Patient Selection

Average-risk adults should begin colorectal cancer screening at age 45 years and continue through age 75 years, with screening decisions for ages 76-85 based on prior screening history, health status, and life expectancy. 1

Average-Risk Population

Age to Begin Screening

  • Start screening at age 45 years for all average-risk adults using either high-sensitivity stool-based tests or structural examinations. 1
  • The American Cancer Society updated their recommendation from age 50 to 45 years to address rising colorectal cancer incidence in younger adults. 1
  • Traditional guidelines recommended age 50 years, but more recent evidence supports earlier initiation. 2

Age to Stop Screening

  • Continue regular screening through age 75 years if patients are in good health with life expectancy greater than 10 years. 1
  • For ages 76-85 years: Screen only if no prior screening history exists, considering comorbidities and life expectancy. 1
  • Discontinue screening after age 85 years or when life expectancy is less than 10 years. 2, 1
  • Patients up-to-date with screening who have negative results (particularly colonoscopy) can stop at age 75 years. 2

Definition of Average Risk

Average-risk patients are defined as those who are:

  • 50 years or older (or 45 years by newer guidelines) 2, 1
  • No personal history of colorectal polyps, colorectal cancer, or inflammatory bowel disease 2
  • No family history of colorectal cancer in a first-degree relative diagnosed before age 60, or two first-degree relatives diagnosed at any age 2
  • No family history of adenomatous polyps in a first-degree relative diagnosed before age 60 2

High-Risk Populations Requiring Earlier/More Frequent Screening

African Americans

  • Begin screening at age 45 years due to higher disease burden and incidence rates. 2, 1
  • Some guidelines suggest age 40 years for African Americans. 2

Family History of Colorectal Cancer or Advanced Adenomas

First-degree relative with colorectal cancer or advanced adenoma diagnosed before age 60, OR two first-degree relatives at any age:

  • Begin colonoscopy at age 40 years OR 10 years before the youngest affected relative's diagnosis, whichever is earlier. 2, 1
  • Repeat colonoscopy every 5 years. 2, 3

Single first-degree relative diagnosed at age 60 or older:

  • Begin average-risk screening options at age 40 years. 2, 3
  • Can follow standard screening intervals with earlier initiation. 2

Inflammatory Bowel Disease

Ulcerative colitis or Crohn's disease with colonic involvement:

  • Begin colonoscopy 8 years after onset of pancolitis or 12-15 years after onset of left-sided colitis. 2, 4
  • Repeat colonoscopy every 1-2 years with biopsies for dysplasia surveillance. 2, 4

Hereditary Syndromes

Familial Adenomatous Polyposis (FAP):

  • Begin annual flexible sigmoidoscopy at age 10-12 years. 2
  • Provide genetic counseling and consider genetic testing. 2

Hereditary Nonpolyposis Colorectal Cancer (HNPCC/Lynch Syndrome):

  • Begin colonoscopy at age 20-25 years OR 10 years before the youngest affected relative's diagnosis. 2
  • Repeat colonoscopy every 1-2 years. 2, 4
  • Genetic counseling and testing should be offered. 2, 4

Peutz-Jeghers Syndrome:

  • Begin colonoscopy at age 8 years. 4
  • If normal, repeat at age 18 years, then every 3 years. 4

Sessile Serrated Adenomatous Polyposis:

  • Begin annual colonoscopy as soon as diagnosis is established. 4

Personal History of Adenomatous Polyps

Advanced adenomas (≥1 cm, villous features, or high-grade dysplasia):

  • Repeat colonoscopy within 1-3 years after polypectomy. 2
  • If no recurrence, extend interval to 3-5 years. 2

Large or multiple adenomatous polyps:

  • Colonoscopy 3 years after initial polypectomy. 2
  • Subsequent intervals depend on findings (5 years if normal or single small tubular adenoma). 2

Personal History of Colorectal Cancer

  • Patients with resected colorectal cancer require surveillance colonoscopy with intervals determined by clinical judgment and tumor characteristics. 2

Symptomatic Patients Under Age 50

Adults under age 50 with colorectal bleeding symptoms (hematochezia, unexplained iron deficiency anemia, melena with negative upper endoscopy):

  • Undergo colonoscopy or sufficient evaluation to determine bleeding cause regardless of screening age recommendations. 2
  • This addresses the rising incidence of colorectal cancer in younger adults. 2, 3

Common Pitfalls to Avoid

  • Do not delay screening in African Americans—they have higher incidence and should begin at age 45 years (or 40 years by some guidelines). 2, 1
  • Do not use average-risk protocols for patients with family history—they require earlier and more frequent colonoscopy. 2
  • Do not continue screening indefinitely—overuse of colonoscopy in elderly patients, particularly over age 80, is a documented problem. 2
  • Do not ignore symptoms in younger patients—colorectal cancer incidence is rising in those under 50 years. 2, 3
  • Ensure positive stool-based tests are followed by colonoscopy—failure to follow up negates screening benefits. 1

References

Guideline

Colorectal Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.